Science Talk

This year, our Spring Appeal is focused on hard-to-treat cancers. These include lung cancer, for which there is still a lack of effective treatments. Although researchers are making progress against the disease, they are sometimes hampered by the stigma that surrounds it because of its well-known link with smoking. Here, we speak with one of the ICR’s lung cancer experts, Dr Astero Klampatsa, to find out more.

Michael Parry was diagnosed with pancreatic cancer at the age of 59. Fortunately, his disease was detected early – and after surgery and chemotherapy, he is now planning for the years ahead with his family. Here he tells his story and explains why more research into hard-to-treat cancers is so vital.

Karen, 59, was told she only had months to live when she was diagnosed with bowel cancer seven years ago. Now, she lives 'near normal life' on a combination of chemotherapy and the targeted drug cetuximab. Here she tells her story.